Matches in Nanopublications for { ?s ?p "[We previously demonstrated that 5-aza-2'-deoxycytidine (DAC) could significantly increase the susceptibility of renal cell carcinoma (RCC) cells to paclitaxel (PTX) treatment in vitro, and showed the synergy of DAC and PTX against RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion description "[We previously demonstrated that 5-aza-2'-deoxycytidine (DAC) could significantly increase the susceptibility of renal cell carcinoma (RCC) cells to paclitaxel (PTX) treatment in vitro, and showed the synergy of DAC and PTX against RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_provenance.